These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7078427)

  • 21. The shunt pathway of mevalonate metabolism in the isolated perfused rat liver.
    Weinstock SB; Kopito RR; Endemann G; Tomera JF; Marinier E; Murray DM; Brunengraber H
    J Biol Chem; 1984 Jul; 259(14):8939-44. PubMed ID: 6430893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro metabolism of mevalonate by sterol and non-sterol pathways.
    Righetti M; Wiley MH; Murrill PA; Siperstein MD
    J Biol Chem; 1976 May; 251(9):2716-21. PubMed ID: 1262340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postnatal development of the sterol and nonsterol mevalonate metabolism in chick liver and kidneys. Effect of cholesterol feeding.
    Aguilera JA; Linares A; Marco C; Arce V; Garcia-Peregrin E
    Ann Nutr Metab; 1984; 28(6):342-9. PubMed ID: 6517527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the diurnal rhythm of mevalonate metabolism by sterol and nonsterol pathways and of mevalonate-activating enzymes.
    Gonzalez-Pacanowska D; Aguilera JA; Arce V; Garcia-Martinez J; Linares A; Garcia-Peregrin E
    Int J Biochem; 1985; 17(2):275-8. PubMed ID: 2989020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low density lipoprotein metabolism in rats with puromycin aminonucleoside-induced nephrotic syndrome.
    Joven J; Masana L; Villabona C; Vilella E; Bargalló T; Trias M; Figueras M; Turner PR
    Metabolism; 1989 May; 38(5):491-5. PubMed ID: 2725289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dietary cholesterol on mevalonate metabolism by sterol and nonsterol pathways.
    Aguilera JA; Linares A; Arce V; Garcia-Peregrin E
    Biochem Biophys Res Commun; 1984 Aug; 122(3):945-8. PubMed ID: 6477574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal excretion mechanisms of the antiviral nucleoside analogue AM 188 in the rat isolated perfused kidney.
    Wang J; Nation RL; Evans AM; Cox S
    Clin Exp Pharmacol Physiol; 2004; 31(1-2):29-34. PubMed ID: 14756681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of thyroid hormone status on mevalonate metabolism in rats.
    Feingold KR; Wiley MH; MacRae G; Siperstein MD
    J Clin Invest; 1980 Oct; 66(4):646-54. PubMed ID: 7419712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper and zinc metabolism in aminonucleoside-induced nephrotic syndrome.
    Pedraza-Chaverrí J; Torres-Rodríguez GA; Cruz C; Mainero A; Tapia E; Ibarra-Rubio ME; Silencio JL
    Nephron; 1994; 66(1):87-92. PubMed ID: 8107960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased glomerular atrial natriuretic peptide receptor affinity in experimental nephrotic syndrome.
    Morgan TR; Morgan K; Vaziri ND; Pandian MR
    Life Sci; 1992; 51(5):337-44. PubMed ID: 1320716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of intracerebrally injected mevalonate in brain of suckling and young adult rats.
    Johnson RC; Shah SN
    Neurochem Res; 1985 May; 10(5):677-89. PubMed ID: 3925358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of the in vivo metabolism of mevalonic acid in the neonatal chick.
    Linares A; Aguilera JA; Arce V; Garcia-Peregrin E
    Int J Biochem; 1983; 15(12):1477-80. PubMed ID: 6418581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between serum albumin concentration and tubular reabsorption of glucose in renal disease.
    Usberti M; Federico S; Cianciaruso B; Costanzo R; Russo D; Andreucci VE
    Kidney Int; 1979 Nov; 16(5):546-51. PubMed ID: 548598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro metabolism of mevalonate by sterol and nonsterol pathways in neonatal chick.
    Aguilera JA; Linares A; Arce V; García-Peregrín E
    Comp Biochem Physiol B; 1982; 71(4):617-21. PubMed ID: 6806006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
    Klein DJ; Dehnel PJ; Oegema TR; Brown DM
    Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental nephrotic syndrome induced in the rat by puromycin aminonucleoside: hepatic synthesis of neutral lipids and phospholipids from 3H-water and 3H-palmitate.
    Gherardi E; Calandra S
    Lipids; 1980 Feb; 15(2):108-12. PubMed ID: 7374358
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat.
    Garin EH; Barratt TM
    Clin Exp Immunol; 1982 Sep; 49(3):639-44. PubMed ID: 7172499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pravastatin sodium on mevalonate metabolism in common marmosets.
    Miyazaki A; Koieyama T; Shimada Y; Kikuchi T; Nezu H; Ito K; Kasanuki N; Koga T
    J Biochem; 2002 Sep; 132(3):395-400. PubMed ID: 12204108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo microvascular clearance of albumin in renal and extrarenal tissues in puromycin aminonucleoside (PAN) induced nephrotic syndrome.
    Oqvist BW; Rippe A; Tencer J; Rippe B
    Nephrol Dial Transplant; 1999 Aug; 14(8):1898-903. PubMed ID: 10462268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
    Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
    Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.